Potter Anderson Represents DuPont in Deal to Acquire Biotechnology Assets from Dyadic

November 17, 2015
  |  
Firm News

DuPont Industrial Biosciences (DuPont) has signed an agreement to purchase enzyme and technology assets from Dyadic International, Inc., including Dyadic’s C1 platform, a fungal expression technology for producing enzymes. The transaction will further extend the world-leading biotechnology capabilities of DuPont’s Industrial Biosciences business.  The transaction is expected to close in the fourth quarter 2015, subject to approval by Dyadic stockholders and customary closing conditions.

The Potter Anderson team is led by partners Michael B. Tumas and Roxanne L. Houtman.

Click here for more information.

Related Professionals

Media Contact

Lauren Kornsey, Senior Manager, Marketing and Business Development

About Potter Anderson

Potter Anderson & Corroon LLP is one of the largest and most highly regarded Delaware law firms, providing legal services to regional, national, and international clients. With more than 90 attorneys, the firm’s practice is centered on corporate law, corporate litigation, intellectual property, commercial litigation, bankruptcy, labor and employment, and real estate.

Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.